In the media, Investors STAT: RNA firm GreenLight Biosciences to go public in $1.2 billion deal The company said has 14 products in its pipeline, including a COVID-19 vaccine candidate, a vaccine for influenza, and a gene therapy for sickle cell disease. Continue reading → 11 August 2021 By Patrick 0 Comments